Wordt geladen...
Tyrosine Kinase Inhibitors in Lung Cancer
‘Driver mutations’ are essential for carcinogenesis as well as tumor progression as they confer a selective growth advantage to cancer cells. Identification of driver mutations in growth related protein kinases, especially tyrosine kinases have led to clinical development of an array of tyrosine kin...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3334853/ https://ncbi.nlm.nih.gov/pubmed/22520981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2012.02.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|